Publications &


In our pursuit of scientific advancement we are committed to sharing our acquired knowledge through actively publishing our data in peer-reviewed journals and academic conferences. We aim to provide a deeper understanding through extensive study and analysis on ileal bile acid transporter (IBAT) inhibition, for both the scientific and patient communities.

Latest Research Updates

Filter by topic
  • Show all
  • Alagille syndrome
  • Biliary atresia
  • Health economics and outcomes research
  • IBAT inhibition
  • LIVMARLI (maralixibat)
  • Patient-reported outcomes validation
  • Primary biliary cholangitis
  • Primary sclerosing cholangitis
  • Progressive familial intrahepatic cholestasis
  • Volixibat
Until a relevant regulatory agency has approved a Mirum product for a specific disease or population, any scientific presentations regarding such disease or population are not to be considered instruction on the appropriate use of Mirum products or clinical candidates.